Skip to main content
Premium Trial:

Request an Annual Quote

Celera and City of Hope Cancer Center Partner on SNP Breast Cancer Studies

Premium

R

OCKVILLE, Md.--Celera Genomics and City of Hope Cancer Center of Duarte, Calif., have decided to work together to investigate associations of genetic polymorphisms with breast cancer. Celera retains the rights to use all information generated from the collaboration in its database products, and all intellectual property developed through the joint effort will be owned equally by Celera and City of Hope.

The collaboration combines City of Hope’s pioneering clinical genetics approach with Celera’s DNA sequence information and polymorphism information databases. City of Hope has developed expertise in establishing the genetic basis of disease and Celera has assembled one of the largest sequence databases.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.